Free Trial

Mizuho, KDB, Rep of Turkey US$ Issuers on Tap

PIPELINE

Decent midweek issuance after $11B total priced Tuesday, Bristol-Myers lead

  • Date $MM Issuer (Priced *, Launch #)
  • 02/16 $Benchmark Mizuho 4.25NC3.25 +105a, 4.25NC3.25 FRN/SOFR, 8.25NC7.25 +135a, 20.25Y +140a
  • 02/16 $Benchmark KDB 3Y +60a, 5Y +70a, 10Y +90a
  • 02/16 $Benchmark Rep of Turkey 5Y Sukuk 7.5%a
  • $11B Priced Tuesday
  • 02/15 $6B *Bristol-Myers $1.75B 10Y +95, $1.25B 20Y +115, $2B 30Y +135, $1B 40Y +155
  • 02/15 $1.5B *Enbridge $400M 2Y +63, $600M 2Y FRN/SOFR+63, $500M 3Y +73
  • 02/15 $1B *Norfolk Southern $600M 10Y +95, $400M 31Y +135
  • 02/15 $1B *FactSet WNG $500M 5Y +100, $500M 10Y +145
  • 02/15 $600M *Kimco 10Y +125
  • 02/15 $500M *Israel Electric Corp WNG 10Y +175
  • 02/15 $400M *Kemper 10Y +180

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.